Silencing the Kir4.1 potassium channel subunit in satellite glial cells of the rat trigeminal ganglion results in pain-like behavior in the absence of nerve injury.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Jean-Philippe VitLuc Jasmin

Abstract

Growing evidence suggests that changes in the ion buffering capacity of glial cells can give rise to neuropathic pain. In the CNS, potassium ion (K+) buffering is dependent on the glia-specific inward rectifying K+ channel Kir4.1. We recently reported that the satellite glial cells that surround primary sensory neurons located in sensory ganglia of the peripheral nervous system also express Kir4.1, whereas the neurons do not. In the present study, we show that, in the rat trigeminal ganglion, the location of the primary sensory neurons for face sensation, specific silencing of Kir4.1 using RNA interference leads to spontaneous and evoked facial pain-like behavior in freely moving rats. We also show that Kir4.1 in the trigeminal ganglion is reduced after chronic constriction injury of the infraorbital nerve. These findings suggests that neuropathic pain can result from a change in expression of a single K+ channel in peripheral glial cells, raising the possibility of targeting Kir4.1 to treat pain in general and particularly neuropathic pain that occurs in the absence of nerve injury.

References

Nov 15, 1978·Experimental Brain Research·L HösliE Hösli
Jul 7, 1995·The Journal of Biological Chemistry·T TakumiS Nakanishi
Mar 25, 2000·Neurochemistry International·W Walz
Apr 27, 2000·Neuroscience and Biobehavioral Reviews·P R LamingK Ng
Mar 21, 2001·Nature Reviews. Neuroscience·P G Haydon
May 23, 2001·Progress in Neurobiology·N C Danbolt
Aug 11, 2001·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·K FriedP P Robinson
Oct 26, 2001·Japanese Journal of Pharmacology·Y Horio
May 23, 2002·Brain : a Journal of Neurology·Matthew C KiernanHugh Bostock
May 18, 2004·Neurochemistry International·Julie Wieseler-FrankLinda R Watkins
Feb 22, 2005·Current Medicinal Chemistry·Yong-Jin Wua, Steven I Dworetzky
May 11, 2005·Proceedings of the National Academy of Sciences of the United States of America·Susanne E la FleurAditi Bhargava
May 26, 2005·Brain Research. Brain Research Reviews·Menachem Hanani
Sep 24, 2005·Current Drug Targets·Mouldy Sioud, Per Ole Iversen
Mar 28, 2006·Journal of Cellular and Molecular Medicine·Arthur M Butt, Amanpreet Kalsi
May 6, 2006·The EMBO Journal·Abdelkrim AllouiMichel Lazdunski
Jun 8, 2006·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Masayuki MiyagiKazuhisa Takahashi
Nov 1, 2006·The Journal of Pain : Official Journal of the American Pain Society·Hideaki ObataMichelle Vincler
Dec 15, 2006·Nature·Stephen G Waxman
Dec 15, 2006·Nature·James J CoxC Geoffrey Woods
Dec 16, 2006·Current Pharmaceutical Design·Toru Kobayashi, Kazutaka Ikeda
Apr 5, 2007·Reviews in the Neurosciences·Johannes Gjerstad
Jun 15, 2007·Nature·Katharina ZimmermannPeter W Reeh
Aug 8, 2007·Neurology·C R FertlemanJ B P Stephenson
Sep 18, 2007·Current Opinion in Anaesthesiology·Ulrike M Stamer, Frank Stüber
Oct 19, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Biljana DjukicKen D McCarthy

❮ Previous
Next ❯

Citations

Jun 23, 2010·Neuron Glia Biology·Luc JasminPeter T Ohara
Oct 16, 2010·Nature Medicine·Ke Ren, Ronald Dubner
Sep 24, 2009·The Journal of Biological Chemistry·Cecilea C ClaytonCharles Chavkin
Jan 10, 2009·Cerebral Cortex·Yuichi TanakaTatsuhiro Hisatsune
Aug 22, 2008·Journal of Neurophysiology·Peter T OharaLuc Jasmin
Oct 15, 2009·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Peter T OharaLuc Jasmin
Oct 13, 2012·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Indu Pal Kaur, Gaurav Sharma
Sep 21, 2010·Metabolism: Clinical and Experimental·Johanne Tremblay, Pavel Hamet
Jan 27, 2009·Neuroscience and Biobehavioral Reviews·Mamoru TakedaShigeji Matsumoto
Aug 5, 2008·Brain, Behavior, and Immunity·Fletcher A White, Kathryn J Jones
May 27, 2008·Journal of Neuroscience Methods·Melanie KernisantPeter T Ohara
Dec 3, 2015·The Journal of Headache and Pain·A CsátiK Warfvinge
Mar 11, 2016·Acta Neuropathologica·Sinifunanya E NwaobiMichelle L Olsen
Aug 12, 2008·Journal of Neurochemistry·Michelle L Olsen, Harald Sontheimer
Nov 10, 2012·Brain and Behavior·Agnieszka Krzyzanowska, Carlos Avendaño
Jun 30, 2010·European Journal of Pain : EJP·Alexandra DoehringJörn Lötsch
Apr 30, 2014·Annals of Neurology·Lucas SchirmerBernhard Hemmer
Jul 16, 2015·Clinical and Experimental Pharmacology & Physiology·Kerui GongQing Lin
Dec 31, 2014·Acta neurologica Belgica·Vivek VermaAhad S Ahmed
Jan 28, 2014·Trends in Neurosciences·Christoforos Tsantoulas, Stephen B McMahon
Jun 25, 2013·Pain·Ru-Rong JiMaiken Nedergaard
Aug 25, 2016·Nanomedicine : Nanotechnology, Biology, and Medicine·Pallavi MadhusudananSahadev A Shankarappa
Feb 1, 2017·JCI Insight·Alison Xiaoqiao XieKen D McCarthy
Apr 23, 2011·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Chen-Yu ChiangBarry J Sessle
Sep 29, 2017·International Journal of Molecular Sciences·Mohammad Zakir HossainJunichi Kitagawa
Nov 20, 2018·Journal of Neuroscience Research·Wenguo FanHongwen He
Jan 21, 2010·Physiological Reviews·Hiroshi HibinoYoshihisa Kurachi
Mar 15, 2014·American Journal of Physiology. Gastrointestinal and Liver Physiology·Dan-dan SongYao-zong Yuan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.